JERRY ARMSTRONG: Open Payments
NPI 1679292916 · TYLERTOWN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,938 in 83 payments from 11 companies in 2025. Trend: 2023 $950 · 2024 $1,397 · 2025 $1,938
Food & beverage: $1,932Education: $6
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $390 |
| E.R. Squibb & Sons, L.L.C. | 15 | $311 |
| Janssen Pharmaceuticals, Inc | 13 | $230 |
| Teva Pharmaceuticals USA, Inc. | 7 | $172 |
| Axsome Therapeutics, Inc. | 3 | $161 |
| Lundbeck LLC | 7 | $144 |
| Alkermes, Inc. | 10 | $143 |
| Vanda Pharmaceuticals Inc. | 4 | $142 |
| Otsuka America Pharmaceutical, Inc. | 3 | $109 |
| ABBVIE INC. | 4 | $79 |
Products named: CAPLYTA, COBENFY, INVEGA SUSTENNA, Auvelity, ARISTADA, FANAPT, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across MS — which companies pay providers there.
